Pachano Pesantez Gabriela S, Clayton Anita H
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville.
Focus (Am Psychiatr Publ). 2021 Jan;19(1):39-45. doi: 10.1176/appi.focus.20200039. Epub 2021 Jan 25.
Hypoactive sexual desire disorder (HSDD) is a persistent or recurrent absence of sexual fantasies and desire for sexual activity, causing marked personal distress or interpersonal difficulties. HSDD affects 10% of U.S. women and is associated with depression and other negative emotional states. It is imperative that psychiatrists are competent to make this diagnosis and are aware of available treatment options. A full psychiatric and medical history are necessary to identify potential causes or contributing factors that may need to be addressed first. The authors discuss the diagnostic tools available as well as general diagnostic considerations for psychiatrists. Given its importance in the understanding of the available treatments for this disorder, the pathophysiology behind HSDD is reviewed. The authors emphasize the treatment of HSDD, including general treatment considerations, treatment in the context of depression, and psychotherapy and medications that have been approved by the U.S. Food and Drug Administration.
性欲减退障碍(HSDD)是一种持续性或复发性的缺乏性幻想及对性活动欲望的情况,会导致明显的个人痛苦或人际困难。HSDD影响着10%的美国女性,且与抑郁及其他负面情绪状态相关。精神科医生必须有能力做出这一诊断,并了解可用的治疗选择。完整的精神科和病史对于识别可能需要首先解决的潜在病因或促成因素是必要的。作者讨论了可用的诊断工具以及精神科医生的一般诊断考量。鉴于其在理解该障碍可用治疗方法方面的重要性,本文回顾了HSDD背后的病理生理学。作者强调了HSDD的治疗,包括一般治疗考量、在抑郁背景下的治疗,以及美国食品药品监督管理局批准的心理治疗和药物。